Dale N. Gerding, MD

Research Physician
Edward Hines, Jr. Veterans Affairs Hospital
Hines, Illinois, United States

Disclosure(s): AstraZeneca: Advisor/Consultant; Destiny Pharma: Advisor/Consultant, Licensed IP to Destiny; Sebela: Advisor/Consultant, Licensed IP

Presentation(s):

• 119 - Evolution of Clostridioides difficile Antimicrobial Susceptibility within the epidemic REA Group BI (RT027) and the endemic REA group Y (RT014/020)

  Thursday, October 17, 2024
  12:40 PM – 12:45 PM US PT